NCT04644705View on ClinicalTrials.gov

Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

May 3, 2021

Study Completion Date

May 3, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Niclosamide

Niclosamide will be applied in various dosage steps, galenic preparations and in combination with camostat

DRUG

Placebo

placebo to the interventional drug

Trial Locations (1)

10117

Charité Research Organisation GmbH, Berlin

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Charité Research Organisation GmbH

OTHER

NCT04644705 - Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat | Biotech Hunter | Biotech Hunter